Jon Zugazagoitia

Jon Zugazagoitia is a 41-year-old oncologist from Biscay, Spain, who has been actively involved in clinical trials for new cancer treatments. He has been instrumental in the research surrounding the experimental drug zongertinib, which shows promise in treating lung cancer in non-smokers, especially those with specific genetic markers. His work aims to improve outcomes for patients facing aggressive forms of lung cancer.